Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

Pyott David E I received 671 Alnylam Pharmaceuticals, Inc. shares as an award (Form 4)

Traded May 20, 2026 · Filed May 22, 2026

On May 20, 2026, Pyott David E I (Director) received 671 Alnylam Pharmaceuticals, Inc. shares as an award, leaving 1,582 shares. Filed May 22, 2026 (Form 4).

Awarded
671 shares
Holding after
1,582 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockAward6711,582Direct

Source

View original at SEC

Related